CD19 and B-cell chronic lymphocytic leukemia: For that, we co-cultured primary cells from 11 patients diagnosed with CLL for 48 hours in our co-culture system or in suspension and measured the increase in survival by means of annexinV-PI exclusion, and the proliferation by the percentage of Ki-67 positive CD19+/CD5+ CLL cells.